Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 554 citing articles:

A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 174-186
Open Access | Times Cited: 2769
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 1381
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 2, pp. 359-367
Open Access | Times Cited: 1107
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 757
TGFβ biology in cancer progression and immunotherapy
Rik Derynck, Shannon J. Turley, Rosemary J. Akhurst
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 1, pp. 9-34
Open Access | Times Cited: 647
Fibroblasts as immune regulators in infection, inflammation and cancer
Sarah Davidson, Mark Coles, Tom Thomas, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 704-717
Open Access | Times Cited: 380
Cancer-associated fibroblasts in the single-cell era
Dor Lavie, Aviad Ben‐Shmuel, Neta Erez, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 793-807
Open Access | Times Cited: 337
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2053-2053
Open Access | Times Cited: 311
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 308
Tracking cancer progression: from circulating tumor cells to metastasis
Francesc Castro-Giner, Nicola Aceto
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 291
Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer
Lisa M. Becker, Joyce T. O’Connell, Annie P. Vo, et al.
Cell Reports (2020) Vol. 31, Iss. 9, pp. 107701-107701
Open Access | Times Cited: 220
The mesenchymal context in inflammation, immunity and cancer
Vasiliki Koliaraki, Alejandro Prados, Marietta Armaka, et al.
Nature Immunology (2020) Vol. 21, Iss. 9, pp. 974-982
Closed Access | Times Cited: 213
Cancer associated-fibroblast-derived exosomes in cancer progression
Chao Li, Adilson Fonseca Teixeira, Hong‐Jian Zhu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 212
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 197
Current Perspectives in Cancer Immunotherapy
Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 186
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
Jin Ma, Gonzalo Sánchez‐Duffhues, Marie‐José Goumans, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 186
Origin and functional heterogeneity of fibroblasts
Valerie S. LeBleu, Eric G. Neilson
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 3519-3536
Open Access | Times Cited: 176
Inflammation-Induced Tumorigenesis and Metastasis
Sana Hibino, Tetsuro Kawazoe, Hidenori Kasahara, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5421-5421
Open Access | Times Cited: 172
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape
Madelon M.E. de Jong, Zoltán Kellermayer, Natalie Papazian, et al.
Nature Immunology (2021) Vol. 22, Iss. 6, pp. 769-780
Closed Access | Times Cited: 164
Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer
Rana Mhaidly, Fatima Mechta‐Grigoriou
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 259-272
Open Access | Times Cited: 161
TGF-beta: a master immune regulator
Christopher Larson, Bryan Oronsky, Corey A. Carter, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 5, pp. 427-438
Closed Access | Times Cited: 160
Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Yan Zhao, Meili Shen, Liangqiang Wu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 154
Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy
Yingyue Ding, Yixin Wang, Quanyin Hu
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 151
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Page 1 - Next Page

Scroll to top